<DOC>
	<DOCNO>NCT02313792</DOCNO>
	<brief_summary>The purpose study compare efficacy safety palifermin reduce mucositis patient receive autologous allogeneic stem cell transplantation supportive care .</brief_summary>
	<brief_title>Palifermin Patients Receiving Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Mucositis</mesh_term>
	<criteria>adequate organ function patient receive autologous stem cell transplantation patient receive allogeneic stem cell transplantation use myeloablative conditioning regimen presence concomitant malignancy presence active infection oral mucositis prior stem cell transplantation condition severity oral mucositis evaluate</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Hematopoietic stem cell transplantation</keyword>
	<keyword>Palifermin</keyword>
</DOC>